RT Journal Article SR Electronic T1 Long-term stabilisation of myeloma with curcumin JF BMJ Case Reports FD BMJ Publishing Group Ltd SP bcr2016218148 DO 10.1136/bcr-2016-218148 VO 2017 A1 Abbas Zaidi A1 Maggie Lai A1 Jamie Cavenagh YR 2017 UL http://casereports.bmj.com/content/2017/bcr-2016-218148.abstract AB Myeloma is a haematological malignancy which typically follows a relapsing-remitting course. While treatment can control the myeloma and improve quality of life for given periods of time, remissions generally become progressively shorter with subsequent relapses, and patients ultimately enter a final refractory phase. To help control symptoms and enhance quality of life, some patients use complementary therapies as an adjunct to their conventional therapy. Here, we describe a myeloma patient who started a daily dietary supplement of curcumin when approaching her third relapse. In the absence of further antimyeloma treatment, the patient plateaued and has remained stable for the last 5 years with good quality of life.